EUVIMEDEUVIMED entdecken
Crossref

Transitional care services are cost-effective for older patients with chronic obstructive pulmonary disease in Korea

Übergangspflege-Services sind für ältere Patient:innen mit COPD in Korea kosteneffektiv

Yu Seong Hwang iD, Deog Kyeom Kim iD, Jung-Kyu Lee iD, Eun Young Heo iD, Hyun Woo Lee iD, Su Kyoung Kim iD, Yukyung Park iD, Woo Jin Kim iD, Seon Sook Han iD, Yeon Jeong Heo, Da Hye Moon, Oh Beom Kwon iD und 4 weitere

International Journal for Quality in Health Care · 05.10.2026 · 38 (4)

DOI: 10.1093/intqhc/mzag136 ↗

Auf einen Blick

Bei 417 Patient:innen mit COPD war Transitional care services (TCS) kosteneffektiv. In der 80er-Kohorte war TCS dominant.

Fragestellung

Sind Transitional care services (TCS) bei älteren Patient:innen mit COPD kosteneffektiv?

Methode

Kosten-Nutzen-Analyse mit Markov-Modell; 417 Patient:innen aus 3 Universitätskliniken in Südkorea; TCS vs. übliche Versorgung; 3-Monats-RCT-Daten; 10-Jahres-Horizont.

Ergebnisse

TCS erhöhte die Kosten um USD 2.128,91 und USD 1.133,41 pro Patient in den 60er- und 70er-Kohorten, senkte sie um USD 58,01 in der 80er-Kohorte. Inkrementelle QALYs: 0,155; 0,195; 0,271. ICUR: USD 13.709,60/QALY; USD 5.816,85/QALY; dominant. Bei USD 23.050/QALY lag die Kosteneffektivitätswahrscheinlichkeit bei 55,7 %, 67,9 % und 82,7 %.

Einschränkungen

Weitere Forschung ist nötig, um die langfristigen klinischen und ökonomischen Vorteile zu bestätigen.

Schlussfolgerung der Autor:innen

TCS war über alle Alterskohorten hinweg kosteneffektiv, mit günstigeren wirtschaftlichen Ergebnissen bei älteren Patient:innen und Dominanz in der 80er-Kohorte.

Kernaussagen

  • TCS war in allen Alterskohorten kosteneffektiv.
  • In der 80er-Kohorte war TCS dominant.
  • Die RRs der Wiederaufnahmen trieben die Unsicherheit.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift International Journal for Quality in Health Care, online erschienen am 12.09.2026. Verfasst von Yu Seong Hwang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Policy and Management, Kangwon National University School of Medicine, Chuncheon, Republic of Korea. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Transitional Care. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Patient-Centered Clinical Research Coordinating Center, Ministry of Health & Welfare, Republic of Korea.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transitional care services (TCS) may reduce post-discharge readmissions and improve disease management in patients with chronic obstructive pulmonary disease (COPD). This study evaluated the cost-effectiveness of TCS using state-specific relative risks (RRs) derived from a randomized controlled trial (RCT).

Methods

Between September 2022 and September 2024, 417 patients with COPD discharged from three university hospitals in South Korea were assigned to TCS (n = 210) or usual care (n = 207). State-specific RRs were derived from 3-month RCT outcomes and incorporated into a Markov model with 3-month cycles and a 10-year time horizon. Costs and quality-adjusted life-years (QALYs) were estimated for patients in their 60 s, 70 s, and 80 s. Deterministic sensitivity analysis (DSA) and probabilistic sensitivity analysis (PSA) were performed to assess parameter uncertainty.

Results

In the base-case analysis, TCS increased costs by USD 2,128.91 and USD 1,133.41 per patient in the 60 s and 70 s cohorts, respectively, but reduced costs by USD 58.01 in the 80 s cohort. Incremental QALYs were 0.155, 0.195, and 0.271, respectively. The corresponding incremental cost-utility ratios were USD 13,709.60/QALY and USD 5,816.85/QALY in the 60 s and 70 s cohorts, while TCS was dominant in the 80 s cohort. DSA identified the RR of respiratory-disease readmission as the largest driver of uncertainty, followed by the RR of COPD readmission; the RR of other-disease readmission and TCS intervention cost were also influential. At a willingness-to-pay threshold of USD 23,050/QALY, the probabilities that TCS was cost-effective were 55.7%, 67.9%, and 82.7% for the 60 s, 70 s, and 80 s cohorts, respectively.

Conclusions

This study evaluated the cost-effectiveness of TCS for patients with COPD using state-specific RRs derived from an RCT. TCS was cost-effective across all age cohorts, with more favourable economic outcomes observed in older patients and dominance in the 80 s cohort. These findings support the implementation of TCS for patients with COPD, while further research is needed to confirm its long-term clinical and economic benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveTransitional CareHumansCost-Benefit AnalysisCost-Effectiveness AnalysisAgedRepublic of KoreaFemaleQuality-Adjusted Life YearsMaleMiddle AgedPatient ReadmissionAged, 80 and overMarkov Chains

Autor:innen und Institutionen

  • Department of Health Policy and Management, Kangwon National University School of Medicine, Chuncheon, Republic of Korea.
  • Division of Pulmonary and Critical Care, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
  • Department of Preventive Medicine, Kangwon National University Hospital, Chuncheon, Republic of Korea.
  • Department of Internal Medicine, Kangwon National University Hospital, Chuncheon, Republic of Korea.
  • Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Republic of Korea.

ORCID-Profile: Yu Seong Hwang, Deog Kyeom Kim, Jung-Kyu Lee, Eun Young Heo, Hyun Woo Lee, Su Kyoung Kim, Yukyung Park, Woo Jin Kim, Seon Sook Han, Oh Beom Kwon, Myung Goo Lee, Chang Youl Lee, Heui Sug Jo

Förderung

  • Patient-Centered Clinical Research Coordinating Center
  • Ministry of Health & Welfare, Republic of Korea

Zitieren

APA

Hwang, Y. S., Kim, D. K., Lee, J. K., Heo, E. Y., Lee, H. W., Kim, S. K., Park, Y., Kim, W. J., Han, S. S., Heo, Y. J., Moon, D. H., Kwon, O. B., Lee, M. G., Hong, J. Y., Lee, C. Y., & Jo, H. S. (2026). Transitional care services are cost-effective for older patients with chronic obstructive pulmonary disease in Korea. International Journal for Quality in Health Care, 38(4). https://doi.org/10.1093/intqhc/mzag136

Vancouver

Hwang YS, Kim DK, Lee JK, Heo EY, Lee HW, Kim SK, et al. Transitional care services are cost-effective for older patients with chronic obstructive pulmonary disease in Korea. International Journal for Quality in Health Care. 2026;38(4). doi:10.1093/intqhc/mzag136

BibTeX
@article{Hwang2026,
  author = {Hwang, Yu Seong and Kim, Deog Kyeom and Lee, Jung-Kyu and Heo, Eun Young and Lee, Hyun Woo and Kim, Su Kyoung and Park, Yukyung and Kim, Woo Jin and Han, Seon Sook and Heo, Yeon Jeong and Moon, Da Hye and Kwon, Oh Beom and Lee, Myung Goo and Hong, Ji Young and Lee, Chang Youl and Jo, Heui Sug},
  title = {Transitional care services are cost-effective for older patients with chronic obstructive pulmonary disease in Korea},
  journal = {International Journal for Quality in Health Care},
  year = {2026},
  volume = {38},
  number = {4},
  doi = {10.1093/intqhc/mzag136}
}
Kostenlos starten →